XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements Of Changes In Equity - USD ($)
$ in Thousands
Total
Common And Treasury Stock [Member]
Treasury Stock [Member]
Number Of Shares, Net Of Treasury [Member]
Additional Paid-In Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Parent [Member]
Noncontrolling Interest [Member]
Balance, Number of Shares at Jun. 30, 2020   82,010,217 (24,891,292) 57,118,925          
Balance at Jun. 30, 2020 $ 290,213 $ 80 $ (286,951)   $ 301,489 $ 444,670 $ (169,075) $ 290,213 $ 0
Redeemable Common Stock, Balance at Jun. 30, 2020 84,979                
Exercise of stock option (Note 12) $ 53 $ 0   $ 17,335 53     53  
Exercise of stock option (Note 12), shares 17,335 17,335              
Stock-based compensation charge (Note 12) $ 1,173       1,173     1,173  
Reversal of stock-based compensation charge (Note 12) (297)       (297)     (297)  
Reversal of stock-based compensation charge (Note 12), shares   (510,200)   (510,200)          
Stock-based compensation charge related to equity-accounted investment (Note 5) (40)       (40)     (40)  
Proceeds from disgorgement of shareholders' short-swing profits (Note 21) 98       98     98  
Net loss (39,696)         (39,696)   (39,696) 0
Other comprehensive (loss) income (Note 11) $ 22,901           22,901 22,901 0
Balance, Number of Shares at Mar. 31, 2021 56,626,060 81,517,352 (24,891,292) 56,626,060          
Balance at Mar. 31, 2021 $ 274,405 $ 80 $ (286,951)   302,476 404,974 (146,174) 274,405 0
Redeemable Common Stock, Balance at Mar. 31, 2021 84,979                
Balance, Number of Shares at Dec. 31, 2020   81,505,851 (24,891,292) 56,614,559          
Balance at Dec. 31, 2020 285,261 $ 80 $ (286,951)   302,196 411,178 (141,242) 285,261 0
Redeemable Common Stock, Balance at Dec. 31, 2020 84,979                
Exercise of stock option (Note 12) 35 $ 0     35     35  
Exercise of stock option (Note 12), shares   11,501   11,501          
Stock-based compensation charge (Note 12) 245       245     245  
Reversal of stock-based compensation charge (Note 12) 0       0     0  
Reversal of stock-based compensation charge (Note 12), shares   0   0          
Net loss (6,204)         (6,204)   (6,204) 0
Other comprehensive (loss) income (Note 11) $ (4,932)           (4,932) (4,932) 0
Balance, Number of Shares at Mar. 31, 2021 56,626,060 81,517,352 (24,891,292) 56,626,060          
Balance at Mar. 31, 2021 $ 274,405 $ 80 $ (286,951)   302,476 404,974 (146,174) 274,405 0
Redeemable Common Stock, Balance at Mar. 31, 2021 84,979                
Balance, Number of Shares at Jun. 30, 2021   81,607,912 (24,891,292) 56,716,620          
Balance at Jun. 30, 2021 275,980 $ 80 $ (286,951)   301,959 406,613 (145,721) 275,980 0
Redeemable Common Stock, Balance at Jun. 30, 2021 84,979                
Exercise of stock option (Note 12) $ 760 $ 0     760     760  
Exercise of stock option (Note 12), shares 249,521 249,521   249,521          
Restricted stock granted (Note 12), shares   984,921   984,921          
Stock-based compensation charge (Note 12) $ 1,751       1,751     1,751  
Reversal of stock-based compensation charge (Note 12) (40)       (40)     (40)  
Reversal of stock-based compensation charge (Note 12), shares   (30,000)   (30,000)          
Stock-based compensation charge related to equity-accounted investment (Note 5) 0       0     0  
Net loss (28,727)         (28,727)   (28,727) 0
Other comprehensive (loss) income (Note 11) $ 3,256           3,256 3,256 0
Balance, Number of Shares at Mar. 31, 2022 57,921,062 82,812,354 (24,891,292) 57,921,062          
Balance at Mar. 31, 2022 $ 252,980 $ 80 $ (286,951)   304,430 377,886 (142,465) 252,980 0
Redeemable Common Stock, Balance at Mar. 31, 2022 84,979                
Balance, Number of Shares at Dec. 31, 2021   82,548,464 (24,891,292) 57,657,172          
Balance at Dec. 31, 2021 240,267 $ 80 $ (286,951)   303,804 381,213 (157,879) 240,267 0
Redeemable Common Stock, Balance at Dec. 31, 2021 84,979                
Exercise of stock option (Note 12) 21       21     21  
Exercise of stock option (Note 12), shares   6,668   6,668          
Restricted stock granted (Note 12), shares   257,222   257,222          
Stock-based compensation charge (Note 12) 619       619     619  
Reversal of stock-based compensation charge (Note 12) (5)       (5)     (5)  
Reversal of stock-based compensation charge (Note 12), shares   0   0          
Stock-based compensation charge related to equity-accounted investment (Note 5) (9)       (9)     (9)  
Net loss (3,327)         (3,327)   (3,327) 0
Other comprehensive (loss) income (Note 11) $ 15,414           15,414 15,414 0
Balance, Number of Shares at Mar. 31, 2022 57,921,062 82,812,354 (24,891,292) 57,921,062          
Balance at Mar. 31, 2022 $ 252,980 $ 80 $ (286,951)   $ 304,430 $ 377,886 $ (142,465) $ 252,980 $ 0
Redeemable Common Stock, Balance at Mar. 31, 2022 $ 84,979